Periodic Reporting for period 1 - iMM-CARE (iMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY)

Note: In October 2024, the Instituto de Medicina Molecular (iMM) underwent a merger to become the Gulbenkian Institute for Molecular Medicine (GIMM). The time between the emergence of innovations in healthcare and their practical application for the benefit of human health is...